Fovea Reports Positive Results With Prednisporin(TM) In Persistent Allergic Conjunctivitis

Tuesday, May 5, 2009

Comments

Medical News Today

Fovea Pharmaceuticals announced positive results from its clinical proof-of-concept trial to assess the therapeutic effect of Prednisporin(TM) (FOV1101) in patients with persistent allergic conjunctivitis.

Full Story

The following is a slit lamp photograph of a 60 year old woman with complaints of chronic foreign body sensation. Which of the following is the least likely cause of her condition?
1. keratoconjuncivitis sicca
2. Bell’s Palsy
3. Neurotrophic keratitis
4. Rheumatoid arthritis
5. Keratoconjuncivitis sicca
Check The Answer

VISUPLAN 500 Non-Contact Tonometer
The measurement of intraocular pressure ... view product
SPECTRALIS Diagnostic Imaging Platform
A modular and upgradeable ophthalmic ... view product

View all Featured Products »

Keep up with our latest articles, news and events. Plus, get special offers and more delivered to your inbox.

Like us
on Facebook Follow us
on Twitter

OphthalmologyWeb wants to hear from you. Submit your case studies, clinical pearls, practice management tips, editorial, or other manuscripts.

Learn more about writing for us

AdGlare Leaderboard

Fovea Reports Positive Results With Prednisporin(TM) In Persistent Allergic Conjunctivitis

Comments

Quick Quiz

The following is a slit lamp photograph of a 60 year old woman with complaints of chronic foreign body sensation. Which of the following is the least likely cause of her condition?

AdGlare RMR Ad

Featured Products

VISUPLAN 500 Non-Contact Tonometer

SPECTRALIS Diagnostic Imaging Platform

Follow OphthalmologyWeb

AdGlare RMR2

Write for Us